Healthcare -
Biotechnology - NASDAQ - US
$ 12.54
1.13 %
$ 1.26 B
Market Cap
-12.93
P/E
Price Target
Average
182.52%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
37.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Day One Biopharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for DAWN of $35.4 , with forecasts ranging from
a
low of
$24 to a high of $45 .
DAWN Lowest Price Target
Wall Street Target
24 USD
91.39%
DAWN Average Price Target
Wall Street Target
35.4 USD
182.52%
DAWN Highest Price Target
Wall Street Target
45 USD
258.85%
REVENUE FORECAST
Revenue Forecast Chart DAWN
EBIT FORECAST
EBIT Forecast Chart DAWN
NET INCOME FORECAST
Net Income Chart DAWN